Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-09-054268
Filing Date
2009-10-28
Accepted
2009-10-29 08:06:02
Documents
11
Period of Report
2009-08-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K c91590e10vk.htm 10-K 971269
2 EXHIBIT 4.11 c91590exv4w11.htm EX-4.11 21636
3 EXHIBIT 4.12 c91590exv4w12.htm EX-4.12 106978
4 EXHIBIT 10.19 c91590exv10w19.htm EX-10.19 137343
5 EXHIBIT 10.20 c91590exv10w20.htm EX-10.20 50055
6 EXHIBIT 21.1 c91590exv21w1.htm EX-21.1 699
7 EXHIBIT 23.1 c91590exv23w1.htm EX-23.1 1638
8 EXHIBIT 31.1 c91590exv31w1.htm EX-31.1 4876
9 EXHIBIT 31.2 c91590exv31w2.htm EX-31.2 4905
10 EXHIBIT 32.1 c91590exv32w1.htm EX-32.1 3274
11 GRAPHIC c91590p7159009.jpg GRAPHIC 14442
  Complete submission text file 0000950123-09-054268.txt   1324339
Mailing Address 9 COMMERCIAL BLVD, SUITE 200 NOVATO CA 94949
Business Address 9 COMMERCIAL BLVD, SUITE 200 NOVATO CA 94949 415-382-1390
RAPTOR PHARMACEUTICALS CORP. (Filer) CIK: 0001203944 (see all company filings)

EIN.: 980379351 | State of Incorp.: DE | Fiscal Year End: 0831
Type: 10-K | Act: 34 | File No.: 000-50720 | Film No.: 091143208
SIC: 2834 Pharmaceutical Preparations